Aptargroup ATR
NYSE ATR
$134.80 +1.84 (+1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aptargroup (ATR) Liabilities and Shareholders Equity (2009 - 2026)

Aptargroup (ATR) posted quarterly Liabilities and Shareholders Equity of $5.1 billion for Q2 2026, up 5.5% year-over-year from $4.9 billion in Q2 2025, and up 0.7% on a QoQ basis from $5.1 billion in Q1 2026.

Aptargroup (ATR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Aptargroup has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $5.1 billion in Q2 2026.

  • Liabilities and Shareholders Equity for Q2 2026 came in at $5.1 billion, up 5.5% year-over-year; the trailing twelve-month figure through Jun 2026 was $20.6 billion (up 11.57% YoY), and the FY2025 annual result was $5.3 billion, up 18.51% from the prior year.
  • Liabilities and Shareholders Equity advanced to $5.1 billion in Q2 2026, from $5.1 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $5.3 billion in Q4 2025 and troughed at $4.0 billion in Q3 2022.
  • A 5-year average of $4.6 billion and a median of $4.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The widest annual swing landed in 2022, when Liabilities and Shareholders Equity retreated 2.54%; it then increased 18.51% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $4.2 billion in 2022, then grew by 5.91% to $4.5 billion in 2023, then fell by 0.44% to $4.4 billion in 2024, then advanced by 18.51% to $5.3 billion in 2025, then slipped by 2.28% to $5.1 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $5.1 billion in Q2 2026, $5.1 billion in Q1 2026, and $5.3 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Aptargroup 8.58 Bn 8.38 Bn 365.52 Mn 5.13 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.13 Bn
Mar 31, 2026 5.10 Bn
Dec 31, 2025 5.25 Bn
Sep 30, 2025 5.10 Bn
Jun 30, 2025 4.87 Bn
Mar 31, 2025 4.53 Bn
Dec 31, 2024 4.43 Bn
Sep 30, 2024 4.63 Bn
Jun 30, 2024 4.45 Bn
Mar 31, 2024 4.44 Bn
Dec 31, 2023 4.45 Bn
Sep 30, 2023 4.30 Bn
Jun 30, 2023 4.35 Bn
Mar 31, 2023 4.30 Bn
Dec 31, 2022 4.20 Bn
Sep 30, 2022 4.03 Bn
Jun 30, 2022 4.26 Bn
Mar 31, 2022 4.41 Bn
Dec 31, 2021 4.14 Bn
Sep 30, 2021 4.13 Bn